Suppr超能文献

PIMREG对裸鼠肝癌细胞表型及致瘤能力的临床诊断价值

Clinical diagnostic value of PIMREG on liver cancer cell phenotype and tumorigenic ability in nude mice.

作者信息

Zhang Lei, Peng Kaiyun, Gao Aijun

机构信息

Department of Medical Laboratory Technology, Medical College, Yangzhou Polytechnic College Yangzhou 225009, Jiangsu, PR China.

Clinical Laboratory, Yangzhou Hospital of TCM Yangzhou 225009, Jiangsu, PR China.

出版信息

Am J Transl Res. 2024 Dec 15;16(12):7994-8007. doi: 10.62347/YVEE7827. eCollection 2024.

Abstract

OBJECTIVES

In vitro experiments were manipulated to investigate the effect of the (PICALM-interacting mitotic regulator gene) expression level on the malignant phenotype of liver cancer cells and their tumorigenesis ability in nude mice, and bioinformatics were used to analyze the clinical diagnostic and prognostic value in liver cancer.

METHODS

After liver cancer-related data were obtained from the TCGA database and GTEx database, the differences in expression in liver cancer and normal liver tissue were compared using bioinformatics, and their correlation with the clinical pathological characteristics of liver cancer and the prognosis value were analyzed. A knockdown and overexpression model of was constructed using Huh7 cells. The effect of the expression level on the malignant phenotype of Huh7 cells was tested through CCK-8 and Transwell experiments. At the same time, animal knockdown and overexpression models were constructed to study the effect of the expression level on the tumorigenesis ability in nude mice.

RESULTS

Bioinformatics analysis showed that mRNA was significantly overexpressed in liver cancer tissue (<0.001). There were differences in T-staging (<0.001), pathological staging (=0.002), vascular infiltration (<0.001), histological grading (<0.001), and AFP levels (<0.001) between the high- and low-expression groups. A high expression of is associated with a poor prognosis, manifested as a significant decrease in the overall survival, disease-specific survival, and progression-free survival rates of patients ( values of 0.006, 0.014, and 0.002, respectively). In the overexpression model, the proliferation rate and invasion ability of Huh7 cells were significantly increased, and the tumorigenesis ability of nude mice was significantly enhanced. In the knockdown model, the opposite results were observed.

CONCLUSIONS

The gene is highly expressed in hepatocellular carcinoma, and increasing its expression level can significantly promote the malignant phenotype of liver cancer cells and their tumorigenesis ability in nude mice. Knocking down its expression level has the opposite effect. The expression level of is related to the pathological stages of liver cancer patients, and its elevated expression is a risk factor for poor prognosis. may become a new target for the clinical diagnosis, treatment, and prognosis evaluation of liver cancer.

摘要

目的

通过体外实验研究(与PICALM相互作用的有丝分裂调节基因)表达水平对肝癌细胞恶性表型及其在裸鼠体内致瘤能力的影响,并运用生物信息学分析其在肝癌中的临床诊断及预后价值。

方法

从TCGA数据库和GTEx数据库获取肝癌相关数据后,利用生物信息学比较肝癌组织和正常肝组织中该基因的表达差异,并分析其与肝癌临床病理特征及预后价值的相关性。采用Huh7细胞构建该基因的敲低和过表达模型。通过CCK-8和Transwell实验检测该基因表达水平对Huh7细胞恶性表型的影响。同时构建动物敲低和过表达模型,研究该基因表达水平对裸鼠致瘤能力的影响。

结果

生物信息学分析显示,该基因mRNA在肝癌组织中显著高表达(<0.001)。高表达组和低表达组在T分期(<0.001)、病理分期(=0.002)、血管浸润(<0.001)、组织学分级(<0.001)和甲胎蛋白水平(<0.001)方面存在差异。该基因高表达与预后不良相关,表现为患者总生存、疾病特异性生存和无进展生存率显著降低(分别为0.006、0.014和0.002)。在该基因过表达模型中,Huh7细胞的增殖率和侵袭能力显著增加,裸鼠的致瘤能力显著增强。在敲低模型中,观察到相反的结果。

结论

该基因在肝细胞癌中高表达,提高其表达水平可显著促进肝癌细胞的恶性表型及其在裸鼠体内的致瘤能力。敲低其表达水平则产生相反的效果。该基因的表达水平与肝癌患者的病理分期相关,其表达升高是预后不良的危险因素。该基因可能成为肝癌临床诊断、治疗及预后评估的新靶点。

相似文献

1
Clinical diagnostic value of PIMREG on liver cancer cell phenotype and tumorigenic ability in nude mice.
Am J Transl Res. 2024 Dec 15;16(12):7994-8007. doi: 10.62347/YVEE7827. eCollection 2024.
5
Oncogenic role and prognostic significance of PIMREG in melanoma.
Transl Cancer Res. 2025 Feb 28;14(2):1070-1084. doi: 10.21037/tcr-24-1861. Epub 2025 Feb 26.
7
Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling.
EBioMedicine. 2019 May;43:188-200. doi: 10.1016/j.ebiom.2019.04.001. Epub 2019 Apr 9.
8
Tumor-promoting function of PIMREG in glioma by activating the β-catenin pathway.
3 Biotech. 2021 Aug;11(8):380. doi: 10.1007/s13205-021-02922-5. Epub 2021 Jul 23.
9
Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jun 28;47(6):685-697. doi: 10.11817/j.issn.1672-7347.2022.210786.
10
Pan-Cancer Analysis of PIMREG as a Biomarker for the Prognostic and Immunological Role.
Front Genet. 2021 Sep 14;12:687778. doi: 10.3389/fgene.2021.687778. eCollection 2021.

本文引用的文献

2
Excessive activation of HOXB13/PIMREG axis promotes hepatocellular carcinoma progression and drug resistance.
Biochem Biophys Res Commun. 2022 Oct 1;623:81-88. doi: 10.1016/j.bbrc.2022.07.066. Epub 2022 Jul 19.
3
Demethylzeylasteral targets lactate by inhibiting histone lactylation to suppress the tumorigenicity of liver cancer stem cells.
Pharmacol Res. 2022 Jul;181:106270. doi: 10.1016/j.phrs.2022.106270. Epub 2022 May 21.
5
PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response.
Biochim Biophys Acta Mol Basis Dis. 2022 Jun 1;1868(6):166382. doi: 10.1016/j.bbadis.2022.166382. Epub 2022 Mar 14.
6
Advances in Nanoliposomes for the Diagnosis and Treatment of Liver Cancer.
Int J Nanomedicine. 2022 Feb 26;17:909-925. doi: 10.2147/IJN.S349426. eCollection 2022.
7
Tumor-promoting function of PIMREG in glioma by activating the β-catenin pathway.
3 Biotech. 2021 Aug;11(8):380. doi: 10.1007/s13205-021-02922-5. Epub 2021 Jul 23.
10
Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells.
Breast Cancer. 2019 Nov;26(6):835-845. doi: 10.1007/s12282-019-00991-2. Epub 2019 Jul 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验